Briumvi’s Phase 3 trial of an at-home injection has completed enrollment, testing an under-the-skin version against IV ...
It will soon be time to process spring-born calves, which brings up the topic of best management practices and following Beef ...
A twice-yearly injection could significantly improve blood pressure control when taken as an add-on to existing treatments. | ...
Global Fund to Fight AIDS, Tuberculosis and Malaria are stepping up efforts to broaden access to Gilead's HIV prevention ...
Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of ...
Daily oral PrEP (generic Truvada; Descovy) is effective but adherence-sensitive, and seroconversions in trials correlate with ...
She was eventually diagnosed with a condition linked to a delayed immune reaction to tattoo ink. Read more at ...
Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy data showing that Dupixent significantly reduce ...
ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...
European Commission approves Sanofi & Regeneron’s Dupixent to treat young children with chronic spontaneous urticaria: Paris Wednesday, April 15, 2026, 09:00 Hrs [IST] The Europ ...
Approval in CSU for children two to 11 years of age is based on data from the LIBERTY-CUPID clinical study program, including an extrapolation of efficacy data showing that Dupixent significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results